LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more

Garry Wills by Garry Wills
July 7, 2023
in Business Finance
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


A Rivian logo on an Amazon.com delivery electric van photographed in Chicago, Illinois, on July 21, 2022.

Jamie Kelter Davis | Bloomberg | Getty Images

Check out the companies making headlines in midday trading.

Alibaba — U.S. shares of the Chinese company added 8.8% in afternoon trading. Earlier on Friday, Reuters first reported that Alibaba’s affiliate company, Ant Group, would pay a $984 million fine to Chinese regulators, which would end several years of dispute. Alibaba also launched an AI tool that can generate images from text prompts.

Rivian Automotive — The electric vehicle maker popped more than 16% after Wedbush raised its price target on shares to $30 from $25, citing an improved outlook. The new target price implies shares rallying almost 39% from Thursday’s close.

Levi Strauss — Shares of the jeans maker slumped 6.7% after the company cut its full-year profit forecast on Thursday. Levi Strauss now expects an adjusted $1.10 to $1.20 per share compared to a previous range of $1.30 to $1.40.

First Solar — The solar company climbed 4.6% after receiving a five-year revolving line of credit as well as a guarantee for a $1 billion facility. JPMorgan will serve as the lead arranger for First Solar.

TG Therapeutics — The pharmaceutical company soared more than 10% after Cantor Fitzgerald reiterated an overweight rating on the stock. The firm said it sees sales of TG Therapeutics’ treatment for relapsing forms of multiple sclerosis, Briumvi, to come in above expectations for the second quarter.

Biogen — Shares slipped more than 2% even after the Food and Drug Administration approved its Alzheimer’s treatment, which was developed with Eisai.

DraftKings — The sports betting platform added 5% in midday trading. A day earlier, Jefferies included the stock as one of the stocks the firm is forecasting is set for gains as the company turns the profit corner.

— CNBC’s Hakyung Kim and contributed reporting



Source link

You might also like

Trump threatens to sue JPMorgan Chase for ‘debanking’ him

Smaller companies are rising quickly to challenge Big Tech as AI ‘s best trade

White House economic advisor floats idea of ‘Trump cards’ amid credit card battle with banks

Share30Tweet19
Previous Post

Pochettino tells his Chelsea squad: ‘Move on quickly, or you’re dead’

Next Post

Murray’s Wimbledon dream ends as Tsitsipas wins Centre Court battle

Garry Wills

Garry Wills

Recommended For You

Trump threatens to sue JPMorgan Chase for ‘debanking’ him
Business Finance

Trump threatens to sue JPMorgan Chase for ‘debanking’ him

January 17, 2026
Smaller companies are rising quickly to challenge Big Tech as AI ‘s best trade
Business Finance

Smaller companies are rising quickly to challenge Big Tech as AI ‘s best trade

January 17, 2026
White House economic advisor floats idea of ‘Trump cards’ amid credit card battle with banks
Business Finance

White House economic advisor floats idea of ‘Trump cards’ amid credit card battle with banks

January 16, 2026
Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more
Business Finance

Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more

January 16, 2026
Next Post
Murray’s Wimbledon dream ends as Tsitsipas wins Centre Court battle

Murray’s Wimbledon dream ends as Tsitsipas wins Centre Court battle

Related News

Tether makes first crypto VC fund investment into Arcanum Capital

Tether makes first crypto VC fund investment into Arcanum Capital

December 26, 2024
More than three in five workers have had enough and are looking to leave their current role  – London Business News | London Wallet

More than three in five workers have had enough and are looking to leave their current role  – London Business News | London Wallet

July 5, 2023
Eli Lilly reports positive results from study of thyroid cancer treatment

Eli Lilly reports positive results from study of thyroid cancer treatment

August 22, 2023

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • jutawantoto
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?